The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century
Open accessAbstract
Biliary atresia (BA) is a fibroinflammatory disease of the intrahepatic and extrahepatic biliary tree. Surgical hepatic portoenterostomy (HPE) may restore bile drainage, but progression of the intrahepatic disease results in complications of portal hypertension and advanced cirrhosis in most children. Recognizing that further progress in the field is unlikely without a better understanding of the underlying cause(s) and pathogenesis of the disease, the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsored a research workshop focused on innovative and promising approaches and on identifying future areas of research. Investigators discussed recent advances using gestational ultrasound and results of newborn BA screening with serum direct (conjugated) bilirubin that support a prenatal onset of biliary injury. Experimental and human studies implicate the toxic properties of environmental toxins (e.g., biliatresone) and of viruses (e.g., cytomegalovirus) to the biliary system. Among host factors, sequence variants in genes related to biliary development and ciliopathies, a notable lack of a cholangiocyte glycocalyx and of submucosal collagen bundles in the neonatal extrahepatic bile ducts, and an innate proinflammatory bias of the neonatal immune system contribute to an increased susceptibility to damage and obstruction following epithelial injury. These advances form the foundation for a future research agenda focused on identifying the environmental and host factor(s) that cause BA, the potential use of population screening, studies of the mechanisms of prominent fibrosis in young infants, determinations of clinical surrogates of disease progression, and the design of clinical trials that target subgroups of patients with initial drainage following HPE. (H epatology 2018; 00:000‐000).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wen, J., Zhou, Y., Wang, J., Chen, J., Yan, W., Wu, J. S., Yan, J., Zhou, K., Xiao, Y., Wang, Y., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.31 · Cited by 31
RetractedVascularized and functional human liver from an iPSC-derived organ bud transplant
Takebe, T., Sekine, K., Enomura, M., Koike, H., Kimura, M., Ogaeri, T., Zhang, R.-R., Ueno, Y., Zheng, Y.-W., Koike, N., et al. (2013) · Nature · doi:10.1038/nature12271 · Cited by 2,170
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
Nevens, F., Andreone, P., Mazzella, G., Strasser, S. I., Bowlus, C., Invernizzi, P., Drenth, J. P. H., Pockros, P. J., Regula, J., Beuers, U., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509840 · Cited by 1,131 · cited 1×
“These include bile acid–based therapeutics such as the farnesoid X receptor (FXR) agonist obeticholic acid in primary biliary cholangitis and the modified bile acid norursodeoxycholic acid, which is currently in phase 2 trials in adult primary sclerosing cholangitis.(46,47) FXR agonists suppress bile acid synthesis an…”
BackgroundHartley, J. L., Davenport, M., & Kelly, D. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60946-6 · Cited by 877
Friedman, S. L., Ratziu, V., Harrison, S. A., Abdelmalek, M. F., Aithal, G. P., Caballeria, J., Francque, S., Farrell, G., Kowdley, K. V., Craxi, A., et al. (2018) · Hepatology · doi:10.1002/hep.29477 · Cited by 671
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives
Arab, J. P., Karpen, S. J., Dawson, P. A., Arrese, M., & Trauner, M. (2017) · Hepatology · doi:10.1002/hep.28709 · Cited by 634
Self-citationSerinet, M., Wildhaber, B. E., Broué, P., et al. (2009) · PEDIATRICS · doi:10.1542/peds.2008-1949 · Cited by 463
Hohenester, S., de Buy Wenniger, L. M., Paulusma, C. C., van Vliet, S. J., Jefferson, D. M., Oude Elferink, R. P., & Beuers, U. (2012) · Hepatology · doi:10.1002/hep.24691 · Cited by 315
norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis
Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H.-U., Altorjay, I., Färkkilä, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.009 · Cited by 297
Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes
Asai, A., Miethke, A., & Bezerra, J. A. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.74 · Cited by 279
Self-citationSundaram, S. S., Mack, C. L., Feldman, A. G., & Sokol, R. J. (2017) · Liver Transplantation · doi:10.1002/lt.24640 · Cited by 265
Self-citationBezerra, J. A., Spino, C., Magee, J. C., Shneider, B. L., Rosenthal, P., Wang, K. S., Erlichman, J., Haber, B., Hertel, P. M., Karpen, S. J., et al. (2014) · JAMA · doi:10.1001/jama.2014.2623 · Cited by 198
Self-citationCytomegalovirus-associated biliary atresia: An aetiological and prognostic subgroup
Zani, A., Quaglia, A., Hadzić, N., Zuckerman, M., & Davenport, M. (2015) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2015.03.001 · Cited by 194
Baghdasaryan, A., Fuchs, C. D., Österreicher, C. H., Lemberger, U. J., Halilbasic, E., Påhlman, I., Graffner, H., Krones, E., Fickert, P., Wahlström, A., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.024 · Cited by 187
The Pathogenesis of Biliary Atresia: Evidence for a Virus-Induced Autoimmune Disease
Mack, C. (2007) · Seminars in Liver Disease · doi:10.1055/s-2007-985068 · Cited by 183
Self-citationBiliary atresia and other cholestatic childhood diseases: Advances and future challenges
Verkade, H. J., Bezerra, J. A., Davenport, M., Schreiber, R. A., Mieli-Vergani, G., Hulscher, J. B., Sokol, R. J., Kelly, D. A., Ure, B., Whitington, P. F., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.04.032 · Cited by 181
Self-citationIdentification of a plant isoflavonoid that causes biliary atresia
Lorent, K., Gong, W., Koo, K. A., Waisbourd-Zinman, O., Karjoo, S., Zhao, X., Sealy, I., Kettleborough, R. N., Stemple, D. L., Windsor, P. A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa1652 · Cited by 164
Self-citationBiliary differentiation and bile duct morphogenesis in development and disease
Raynaud, P., Carpentier, R., Antoniou, A., & Lemaigre, F. P. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.07.020 · Cited by 158
Schwarz, K. B., Haber, B. A., Rosenthal, P. J., Mack, C. L., Moore, J., Bove, K. E., Bezerra, J. A., Karpen, S. J., Kerkar, N. N., Shneider, B. L., et al. (2013) · Hepatology · doi:10.1002/hep.26512 · Cited by 150
Self-citationShneider, B. L., Magee, J. C., Karpen, S. J., Rand, E. B., Narkewicz, M. R., Bass, L. M., Schwarz, K. B., Whitington, P. F., Bezerra, J. A., Kerkar, N. N., et al. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.11.058 · Cited by 147
Self-citationSlijepcevic, D., Abbing, R. L. P. R., Katafuchi, T., Blank, A., Donkers, J. M., van Hoppe, S., de Waart, D. R., Tolenaars, D., van der Meer, J. H. M., Wildenberg, M. E., et al. (2017) · Hepatology · doi:10.1002/hep.29251 · Cited by 144
Miethke, A. G., Zhang, W., Simmons, J., Taylor, A. E., Shi, T., Shanmukhappa, S. K., Karns, R., White, S., Jegga, A. G., Lages, C. S., et al. (2016) · Hepatology · doi:10.1002/hep.27973 · Cited by 141
Paracrine signals regulate human liver organoid maturation from iPSC
Asai, A., Aihara, E., Watson, C. L., Mourya, R., Mizuochi, T., Shivakumar, P., Phelan, K. J., Mayhew, C. N., Helmrath, M. A., Takebe, T., et al. (2017) · Development · doi:10.1242/dev.142794 · Cited by 141
Self-citationEvidence From Human and Zebrafish That GPC1 Is a Biliary Atresia Susceptibility Gene
Cui, S., Leyva‐Vega, M., Tsai, E. A., EauClaire, S. F., Glessner, J., Hakonarson, H. H., Devoto, M., Haber, B. A., Spinner, N. B., & Matthews, R. P. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.022 · Cited by 129
Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia
Mack, C. L., Tucker, R. M., Lu, B., Sokol, R. J., Fontenot, A. P., Ueno, Y., & Gill, R. G. (2006) · Hepatology · doi:10.1002/hep.21366 · Cited by 128
Self-citationBiliary Atresia in The Netherlands: Outcome of Patients Diagnosed between 1987 and 2008
de Vries, W., de Langen, Z. J., Groen, H., Scheenstra, R., Peeters, P. M. J. G., Hulscher, J. B. F., & Verkade, H. J. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.09.061 · Cited by 127
Oligoclonal Expansions of CD4+ and CD8+ T-Cells in the Target Organ of Patients With Biliary Atresia
Mack, C. L., Falta, M. T., Sullivan, A. K., Karrer, F. M., Sokol, R. J., Freed, B. M., & Fontenot, A. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.032 · Cited by 119
Self-citationSampaziotis, F., de Brito, M. C., Geti, I., Bertero, A., Hannan, N. R. F., & Vallier, L. (2017) · Nature Protocols · doi:10.1038/nprot.2017.011 · Cited by 119
Brindley, S. M., Lanham, A. M., Karrer, F. M., Tucker, R. M., Fontenot, A. P., & Mack, C. L. (2011) · Hepatology · doi:10.1002/hep.24807 · Cited by 116
Self-citationOmenetti, A., Bass, L. M., Anders, R. A., Clemente, M. G., Francis, H., Guy, C. D., McCall, S. J., Choi, S. S., Alpini, G. D., Schwarz, K. B., et al. (2011) · Hepatology · doi:10.1002/hep.24156 · Cited by 114
Waisbourd‐Zinman, O., Koh, H., Tsai, S. J., Lavrut, P., Dang, C., Zhao, X. Y., Pack, M. A., Cave, J., Hawes, M. C., Koo, K. A., et al. (2016) · Hepatology · doi:10.1002/hep.28599 · Cited by 113
Self-citationShivakumar, P., Sabla, G. E., Mohanty, S., McNeal, M., Ward, R. L., Stringer, K. F., Caldwell, C. C., Chougnet, C. A., & Bezerra, J. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.031 · Cited by 112
Self-citationBessho, K., Mourya, R., Shivakumar, P., Walters, S., Magee, J. C., Rao, M. B., Jegga, A. G., & Bezerra, J. A. (2014) · Hepatology · doi:10.1002/hep.27045 · Cited by 100
Self-citationNg, V. L., Haber, B. A., Magee, J. C., Miethke, A. G., Murray, K. F., Michail, S. K., Karpen, S. J., Kerkar, N. N., Molleston, J. P., Romero, R., et al. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.05.038 · Cited by 97
Self-citationKerola, A., Lampela, H., Lohi, J., Heikkilä, P., Mutanen, A., Hagström, J., Tervahartiala, T. I., Sorsa, T. A., Haglund, C. H., Jalanko, H., et al. (2016) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.50 · Cited by 82
α-Enolase Autoantibodies Cross-Reactive to Viral Proteins in a Mouse Model of Biliary Atresia
Lu, B., Brindley, S. M., Tucker, R. M., Lambert, C. L., & Mack, C. L. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.07.042 · Cited by 81
Self-citationSchreiber, R. A., Masucci, L., Kaczorowski, J. A., COLLET, J.-P., Lutley, P., Espinosa, V., & Bryan, S. (2014) · Journal of Medical Screening · doi:10.1177/0969141314542115 · Cited by 78
Tsai, E. A., Grochowski, C. M., Loomes, K. M., Bessho, K., Hakonarson, H. H., Bezerra, J. A., Russo, P., Haber, B. A., Spinner, N. B., & Devoto, M. (2013) · Human Genetics · doi:10.1007/s00439-013-1368-2 · Cited by 74
Self-citationUemura, M., Ozawa, A., Nagata, T., Kurasawa, K., Tsunekawa, N., Nobuhisa, I., Taga, T., Hara, K., Kudo, A., Kawakami, H., et al. (2013) · Development · doi:10.1242/dev.086702 · Cited by 68
Lages, C. S., Simmons, J. R., Chougnet, C. A., & Miethke, A. G. (2012) · Hepatology · doi:10.1002/hep.25662 · Cited by 67
Lages, C. S., Simmons, J. R., Maddox, A., Jones, K. R., Karns, R. A., Sheridan, R. M., Shanmukhappa, S. K., Mohanty, S., Kofron, M. J., Russo, P., et al. (2016) · Hepatology · doi:10.1002/hep.28851 · Cited by 66
Zhao, X. Y., Lorent, K., Wilkins, B. J., Marchione, D. M., Gillespie, K. P., Waisbourd‐Zinman, O., So, J., Koo, K. A., Shin, D., Porter, J. R., et al. (2016) · Hepatology · doi:10.1002/hep.28603 · Cited by 60
Self-citationTsai, E. A., Grochowski, C. M., Falsey, A. M., Rajagopalan, R., Wendel, D., Devoto, M., Krantz, I. D., Loomes, K. M., & Spinner, N. B. (2015) · Human Mutation · doi:10.1002/humu.22786 · Cited by 54
Mack, C. L. (2015) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2015.04.001 · Cited by 45
Self-citationGene regulatory networks in differentiation and direct reprogramming of hepatic cells.
Gérard, C., Tys, J., & Lemaigre, F. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2016.12.003 · Cited by 40
Adjuvant therapy in biliary atresia: hopelessly optimistic or potential for change?
Davenport, M. (2017) · Pediatric Surgery International · doi:10.1007/s00383-017-4157-5 · Cited by 34
Kerola, A., Lampela, H., Lohi, J., Heikkilä, P., Mutanen, A., Jalanko, H., & Pakarinen, M. P. (2017) · Surgery · doi:10.1016/j.surg.2017.04.013 · Cited by 28
Transplantable Liver Organoids Made from Only Three Ingredients
Willenbring, H., & Soto–Gutiérrez, A. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.07.014 · Cited by 16
Lack of HLA predominance and HLA shared epitopes in biliary Atresia
Mack, C. L., Anderson, K. M., Aubrey, M. T., Rosenthal, P. J., Sokol, R. J., & Freed, B. M. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-42 · Cited by 15
Self-citation
Cited by
Bile Acids as Metabolic Regulators and Nutrient Sensors
Chiang, J. Y. L., & Ferrell, J. M. (2019) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-082018-124344 · Cited by 437
The role of vitamin D and vitamin D binding protein in chronic liver diseases
Pop, T. L., Sîrbe, C., Benţa, G., Mititelu, A., & Grama, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810705 · Cited by 105
“Most patients had progressive liver fibrosis despite the hepatic portoenterostomy (HPE) and evolved toward cirrhosis and end-stage liver disease with the need for liver transplantation (LT) [40].”
BackgroundBiliary organoids uncover delayed epithelial development and barrier function in biliary atresia
Amarachintha, S. P., Mourya, R., Ayabe, H., Yang, L., Luo, Z., Li, X., Thanekar, U., Shivakumar, P., & Bezerra, J. A. (2022) · Hepatology · doi:10.1002/hep.32107 · Cited by 98
Self-citationLiver organoids: established tools for disease modeling and drug development
Sun, X.-C., Kong, D.-F., Zhao, J., Faber, K. N., Xia, Q., & He, K. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000105 · Cited by 37
Mesenchymal stem cell therapy as a game-changer in liver diseases: review of current clinical trials
Huang, W.-C., Li, Y.-C., Chen, P.-X., Ma, K. S.-K., & Wang, L.-T. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04127-y · Cited by 29
Metadata
- Authors
- Bezerra, J. A., Wells, R. G., Mack, C. L., Karpen, S. J., Hoofnagle, J. H., Doo, E., & Sokol, R. J.
- Venue
- Hepatology
- Published
- 2018-09
- Volume
- 68
- Issue
- 3
- Pages
- 1163-1173
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2794632001
- Cited by
- 343
- References
- 49
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.